CB
Connaughton Bernadette
Director
OFFICERF
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Connaughton Bernadette, Director. Officer active across 2 companies, notably Halozyme Therapeutics, INC.. Cumulatively, 18 filings have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €717k. Activity tracked since 5 May 2021. The latest transaction was filed on 10 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Connaughton Bernadette
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
1,626 股@ US$102.80Common StockSEC:0001662521-26-000002:0
1,625 股@ US$66.210.0011% mcap18.2% 占其流量Common StockSEC:0001159036-26-000072:0
1,625 股@ US$63.480.0011% mcap21.1% 占其流量Common StockSEC:0001159036-26-000055:0
2,000 股@ US$70.250.0015% mcap28.9% 占其流量Common StockSEC:0001159036-26-000006:0
829 股@ US$71.608.9% 占其流量Common StockSEC:0001159036-25-000065:0
2,000 股@ US$68.4822.8% 占其流量Common StockSEC:0001159036-25-000052:0
1,500 股@ US$75.08623.8% 占其流量Common StockSEC:0001662521-25-000005:0
100 股@ US$71.712.0% 占其流量Common StockSEC:0001415889-25-023470:0
4,165 股0Common StockSEC:0001415889-25-011767:0
6,501 股0Common StockSEC:0001415889-24-011679:0
9,915 股@ US$43.00100.0% 占其流量Class A Common StockSEC:0001209191-23-050772:0
4,863 股0Class A Common StockSEC:0001209191-23-032940:0
8,065 股0Common StockSEC:0001415889-23-007688:0
5,998 股0Common StockSEC:0001415889-22-011511:0
2,839 股0Class A Common StockSEC:0001209191-22-032624:0
6,206 股0Restricted Stock UnitsSEC:0001179110-22-002907:0
2,364 股0Class A Common StockSEC:0001209191-21-032806:0
5,230 股0Restricted Stock UnitsSEC:0001179110-21-004970:0
About Connaughton Bernadette
Connaughton Bernadette is a Director at Halozyme Therapeutics, INC. and Syneos Health, Inc. She has 17 filings in total. In the sampled recent filings from 2021-05-06 to 2026-06-02, the total sell amount is EUR 976217 and the most frequent transaction nature is Attribution.